Outlook Therapeutics (OTLK) Cash & Current Investments: 2015-2019
Historic Cash & Current Investments for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $8.0 million.
- Outlook Therapeutics' Cash & Current Investments rose 70.77% to $24.0 million in Q2 2020 from the same period last year, while for Jun 2020 it was $38.0 million, marking a year-over-year increase of 135.35%. This contributed to the annual value of $8.0 million for FY2019, which is 366.73% up from last year.
- As of FY2019, Outlook Therapeutics' Cash & Current Investments stood at $8.0 million, which was up 366.73% from $1.7 million recorded in FY2018.
- In the past 5 years, Outlook Therapeutics' Cash & Current Investments registered a high of $9.1 million during FY2015, and its lowest value of $1.7 million during FY2018.
- Over the past 3 years, Outlook Therapeutics' median Cash & Current Investments value was $3.2 million (recorded in 2017), while the average stood at $4.3 million.
- Its Cash & Current Investments has fluctuated over the past 5 years, first crashed by 74.07% in 2016, then spiked by 366.73% in 2019.
- Over the past 5 years, Outlook Therapeutics' Cash & Current Investments (Yearly) stood at $9.1 million in 2015, then tumbled by 74.07% to $2.4 million in 2016, then surged by 35.45% to $3.2 million in 2017, then tumbled by 46.09% to $1.7 million in 2018, then skyrocketed by 366.73% to $8.0 million in 2019.